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Vertebrate intestinal surfaces are in constant contact with a vast consortium of commensal bacteria.
To preserve mutually beneficial host-microbial relationships, gut epithelia have evolved strategies to
limit the proinflammatory potential of resident gut microbes. In this issue of Cell Host & Microbe,
Bates and colleagues report that intestinal alkaline phosphatase, whose expression is induced
during establishment of the microbiota, dephosphorylates lipopolysaccharide and promotes
mucosal tolerance to commensal bacteria in zebrafish.Most vertebrates harbor complex
communities of coevolved bacteria in
their intestines. In humans, this con-
sortium is comprised of thousands of
distinct species and as many as 10
to 100 trillion organisms (Turnbaugh
et al., 2007). These bacteria make im-
portant contributions to the health of
their hosts by increasing the efficiency
of digestion and synthesizing essential
vitamins. In addition, indigenous mi-
crobial communities help to protect
the host by occupying niches that
might otherwise harbor pathogenic
organisms.
Despite the benefits conferred by
their prokaryotic partners, humans
and other vertebrates must cope with
several serious problems posed by
a close relationship with dense micro-
bial populations. One issue is how to
manage the threat of microbial inva-
sion from large bacterial communities.
This has been solved in part through
the evolution of mechanisms, such
as secretion of antimicrobial proteins
and immunoglobulins, which compart-
mentalize microbes on the luminal side
of the gut epithelial barrier. However,
another problem involves the vast
amount of lipopolysaccharide (LPS)
that is produced by the luminal micro-
flora. LPS is a major constituent of
Gram-negative bacterial cell walls,
which is recognized by the innate im-
mune system, eliciting inflammatory
responses that are designed to clear
bacterial infections. The major recep-
tor for LPS in mammals is Toll-likereceptor 4 (TLR4), which triggers sig-
naling cascades through MyD88, an
adaptormolecule that functions down-
stream of multiple TLRs. TLR activa-
tion leads to proinflammatory cytokine
expression (e.g., tumor necrosis fac-
tor), neutrophil recruitment to infected
sites, and systemic responses such
as fever. At high concentrations, LPS
becomes toxic by overstimulating
TLR4 signaling, leading to an exces-
sive inflammatory response that re-
sults in adverse reactions such as
septic shock. Since a large fraction of
the intestine’s indigenous bacteria are
Gram-negative, the load of LPS in the
gut is enormous. However, in healthy
humans, indicators of intestinal inflam-
mation such as neutrophil presence
are minimal (Neish, 2002). So, given
the presence of 100 trillion bacteria
and their associated LPS, why isn’t
the gut continuously inflamed?
In this issue of Cell Host & Microbe,
Bates et al. (2007) make significant
progress toward resolving this para-
dox by uncovering a mechanism
whereby LPS is detoxified at the gut
epithelial surface. They have utilized
a zebrafish model, which has key
advantages as a system for dissect-
ing host-bacterial associations. As in
mice, zebrafish have a complex intes-
tinal microbiota (Rawls et al., 2004)
and can be reared germ-free, allow-
ing manipulation of the intestine’s
bacterial colonizers for the study of
host-bacterial relationships. However,
in contrast to mice, zebrafish geneCell Host & Microbe 2, Dexpression is easilymanipulated through
morpholino antisense technology, mak-
ing it possible to routinely elucidate
the contributions of specific host
genes to maintaining host-microbial
associations. Bates et al. (2007) have
further demonstrated that zebrafish,
likemammals, respond to LPS through
a MyD88-dependent mechanism that
induces recruitment of neutrophils
into the intestine and elicits toxic re-
sponses to high LPS concentrations.
To resolve the question of how the
vertebrate intestine copes with high
LPS loads, Bates et al. (2007) focused
on alkaline phosphatases (APs), a class
of enzymes that are prominent in the
gut. Although alkaline phosphatases
have been proposed to play a role in
the breakdown of dietary lipids, they
can also dephosphorylate the lipid
moiety of LPS, resulting in reduced
LPS toxicity in mammals (Koyama
et al., 2002). When Bates et al. (2007)
colonized germ-free zebrafish with
a normal microbiota or exposed them
to purified LPS, they induced expres-
sion of an intestine-specific isoform of
alkaline phosphatase (IAP) that associ-
ates specifically with the apical brush
border of gut epithelial cells (Bates
et al., 2006). Morpholino knockdown
of MyD88 revealed that IAP is induced
through a MyD88-dependent mecha-
nism, suggesting that its expression is
governed by TLRs.
What is the functional significance
of microflora-induced IAP expression?
To answer this question, Bates et al.ecember 2007 ª2007 Elsevier Inc. 365
Figure 1. IAP Is Part of a Negative Feedback Loop that
Senses LPS and Activates a Detoxification Mechanism that
Maintains Homeostasis at the Gut Epithelial Surface
Intestinal alkaline phosphatase (IAP) is expressed under the control of
LPS from the normal microbiota. The enzyme localizes to the apical
brush border of intestinal epithelial cells and removes phosphates
from glutamines in the LPS lipid A moiety. Unlike intact LPS, dephos-
phorylated LPS fails to activate MyD88-dependent TLR signaling that
promotes proinflammatory responses including neutrophil recruit-
ment. Although TLRs are depicted as having an epithelial localization,
the cellular origin of the TLR signaling in this model has not yet been
established. (Illustration courtesy of Chris Etheredge.)
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that dephosphorylated LPS
is less toxic to zebrafish.
Morpholino knockdown ex-
periments revealed that IAP
suppresses LPS mediated
toxicity to zebrafish, as
would be predicted on the
basis of its LPS dephos-
phorylating activity. More-
over, in the absence of IAP,
gut microflora elicited ab-
normally high levels of neu-
trophil recruitment to the
small intestine, indicating
that IAP plays a key role in
suppressing proinflamma-
tory responses to commen-
sal microbes.
These findings suggest
that IAP acts as a micro-
flora-controlled LPS de-
toxifying mechanism that
functions at the epithelial
surface. In this way, IAP is
part of a negative feedback
loop that senses and detox-
ifies LPS in order to maintain
homeostasis (Figure 1). As
microflora-driven expres-
sion of IAP requires MyD88,
this indicates that MyD88-
dependent TLR signaling
not only activates proinflam-
matory pathways, but also
triggers anti-inflammatory
responses that maintain ho-
meostasis with the normal
flora. The discovery that
IAP modifies the proinflam-
matory potential of LPS isreminiscent of a mammalian LPS de-
toxification mechanism that involves
the enzyme acyloxyacyl hydrolase
(AOAH). AOAH is expressed systemi-
cally, and cleaves acyl chains from
the lipid A portion of LPS such that
it is no longer recognized by TLR4,
thereby preventing prolonged sys-
temic inflammatory reactions following
Gram-negative infections (Lu et al.,
2005; Shao et al., 2007).
The localization of IAP to the apical
surface of epithelial cells suggests
a mechanism whereby LPS from the
luminal microflora is detoxified while
LPS from invading pathogens acti-
vates appropriate proinflammatory
responses. As a result of its apical366 Cell Host & Microbe 2, December 200location, IAP likely modifies luminal
LPS specifically at the epithelial sur-
face while leaving intact LPS that is
encountered in subepithelial tissues.
Thus, in the event of bacterial invasion
across the epithelial barrier, the un-
modified subepithelial LPS could
activate the inflammatory responses
required to clear bacterial infection.
A crucial remaining question con-
cerns the cellular localization of the
TLRs that drive the LPS responses un-
covered by this study. One plausible
model would place the relevant TLRs
on the surface of epithelial cells, where
they could be accessed by LPS from
the luminal microflora. However, this
model must account for the fact that7 ª2007 Elsevier Inc.LPS can drive distinct
anti- and proinflammatory
responses. Bates et al.
(2007) have shown that
under homeostatic condi-
tions, microflora-derived
LPS elicits anti-inflamma-
tory expression of IAP. In
contrast, in the absence of
IAP or in the presence of
excess LPS, inflammatory
responses, including neu-
trophil recruitment, are trig-
gered. One way to explain
these findings is to propose
that intact LPS must ex-
ceed a threshold concen-
tration in order to activate
inflammatory pathways. In
this model, the choice of
whether to mount an anti-
inflammatory or proinflam-
matory response would
thus be governed both by
the affinity of LPS binding
to its receptor(s) and the
rate at which IAP dephos-
phorylates LPS.
Although it remains to be
determined whether IAP
performs a similar function
at the mammalian intestinal
surface, the activity of this
enzyme increases during
postembryonic establish-
ment of the microbiota in
both fish (Bates et al.,
2006) and mammals (Hen-
ning, 1985). This suggests
that IAP may contribute
to maintaining mutualisticbacterial-host relationships in both
groups. If so, the findings from the
Bates et al. (2007) study could lead to
new insight into human disorders,
such as inflammatory bowel disease,
which are characterized by dysregu-
lated inflammatory responses to intes-
tinal microbes.
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Conjugation of ubiquitin regulates multiple pathways, including the signaling cascades leading to
antiviral immunity. Similarly, the ubiquitin-like peptide ISG15 mediates the antiviral response to certain
viruses. In this issue of Cell Host & Microbe, Frias-Staheli and colleagues demonstrate that research
on viral proteases of certain nairoviruses and arteriviruses reveals the presence of ovarian tumor
domain-containing sequences that act as general deubiquitinases and deISGylases and increase
viral replication by inhibiting the antiviral response mediated by ISG15.Coevolution of viruses and their natu-
ral hosts has provided these versatile
pathogens countless opportunities to
develop and diversify mechanisms of
evasion of the host immune response.
The innate immune response to vi-
ruses is in part regulated by the pro-
duction of type I interferon (IFN), a fam-
ily of cytokines that signals through its
cognate IFN receptors and the Janus
kinase (JAK)/signal transducer and
activator of transcription (STAT) path-
way, leading to the expression of hun-
dreds of genes with antiviral activity.
Detection of viral components by the
Toll-like receptor (TLR) system or the
cytoplasmic RNA helicases RIG-I and
Mda5 activates the IFN pathway by
signaling to the kinases IKK3/TBK1
to phosphorylate interferon regulatory
factors 3 and 7 (IRF3/IRF7) and induce
expression of IFN and IFN-stimulated
genes (ISGs) (Hiscott, 2007; Seth et al.,
2006). Simultaneously, the inflamma-
tory response is triggered through the
IkB kinase (IKK) complex, leading to
proteasomal degradation of the inhibi-
tor of NF-kB (IkB), release of NF-kB,and transcriptional stimulation of
NF-kB target genes (Hacker and Karin,
2006).
Activation and shutdown of these
two pathways is carefully orchestrated
by posttranslational modification
events. Although initial focus was di-
rected to phosphorylation events, it is
now clear that addition and removal
of ubiquitin chains is also a major reg-
ulatory mechanism that controls IRF
and NF-kB activation (Hacker and
Karin, 2006). Addition of K63-linked
ubiquitin chains—as in the case of
TRAF3 (TNF receptor-associated fac-
tor 3), TRAF6, and the IKK regulatory
subunits NEMO and RIG-I—generally
favors protein-protein interactions and
activation of downstream signaling.
Conversely, removal of K63-linked
chains negatively impacts NF-kB and
IRF activation. The deubiquitinase
(DUB) A20 is a negative regulator of
the classical NF-kB pathway that ter-
minates tumor necrosis factor a recep-
tor-, TLR-, and RIG-I-mediated NF-kB
activation (Wertz et al., 2004; Liu et al.,
2005). A20 also negatively regulatesthe IFN pathway following TLR3 or
RIG-I stimulation (Lin et al., 2006).
A20 belongs to the ovarian tumor
(OTU) domain DUBs—a family of pro-
teins that have been poorly character-
ized in terms of physiological function.
Very recently, the Dixit lab at Genen-
tech used a genome wide siRNA
screen to search for novel regulators
of interferon signaling and identified
DUBA (deubiquitinating enzyme A) as
a novel OTU-domain DUB that nega-
tively regulates IFN signaling follow-
ing RIG-I, Mda5, or TLR3 stimulation
(Kayagaki et al., 2007). DUBA specifi-
cally removed K63-linked ubiquitin
chains from TRAF3, resulting in the
disruption of interaction between
TRAF3 and the downstream kinases
IKK3 and TBK1 and blockade of IRF3
and IRF7 phosphorylation. Surpris-
ingly, DUBA had no effect on process-
ing of the NF-kB precursor NF-kB2/
p100 into the active subunit p52,
although TRAF3 is intimately involved
in the noncanonical NF-kB pathway.
Among the ISGs, ISG15 is a 15 kDa
protein that is able to covalentlyecember 2007 ª2007 Elsevier Inc. 367
